{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T20:26:15Z","timestamp":1774470375309,"version":"3.50.1"},"reference-count":96,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,26]],"date-time":"2024-02-26T00:00:00Z","timestamp":1708905600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007496","name":"VA Biomedical Laboratory Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007496","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012542","name":"Sichuan Province Science and Technology Support Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014895","name":"Southwest Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014895","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajp.amjpathol.org","clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Pathology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.ajpath.2024.02.006","type":"journal-article","created":{"date-parts":[[2024,2,28]],"date-time":"2024-02-28T09:49:11Z","timestamp":1709113751000},"page":"879-893","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["The Role of miRNA and Long Noncoding RNA in Cholestatic Liver Diseases"],"prefix":"10.1016","volume":"194","author":[{"given":"Yudian","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Huo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Longfei","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bowen","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fanyin","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenggang","family":"Duan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingru","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinbo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Xing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5909-2892","authenticated-orcid":false,"given":"Ying","family":"Wan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajpath.2024.02.006_bib1","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.cgh.2007.05.008","article-title":"Diagnosis and management of cholestatic liver disease","volume":"5","author":"Heathcote","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.ajpath.2024.02.006_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-pathol-042320-115255","article-title":"Long noncoding RNAs and human liver disease","volume":"17","author":"DiStefano","year":"2022","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.ajpath.2024.02.006_bib3","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1186\/s12967-023-04642-1","article-title":"LncRNA-Gm9866 promotes liver fibrosis by activating TGFbeta\/Smad signaling via targeting Fam98b","volume":"21","author":"Liao","year":"2023","journal-title":"J Transl Med"},{"key":"10.1016\/j.ajpath.2024.02.006_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2019.116829","article-title":"LncRNA NEAT1 promotes hepatic lipid accumulation via regulating miR-146a-5p\/ROCK1 in nonalcoholic fatty liver disease","volume":"235","author":"Chen","year":"2019","journal-title":"Life Sci"},{"key":"10.1016\/j.ajpath.2024.02.006_bib5","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/978-981-15-3449-2_10","article-title":"Epigenetics of primary biliary cholangitis","volume":"1253","author":"Li","year":"2020","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.ajpath.2024.02.006_bib6","article-title":"The roles and mechanisms of lncRNAs in liver fibrosis","volume":"12","author":"Wang","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ajpath.2024.02.006_bib7","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/MOG.0000000000000051","article-title":"MicroRNAs and cholestatic liver diseases","volume":"30","author":"Marin","year":"2014","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.ajpath.2024.02.006_bib8","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3350\/cmh.2020.0166","article-title":"Long non-coding RNAs in liver diseases: focusing on nonalcoholic fatty liver disease, alcohol-related liver disease, and cholestatic liver disease","volume":"26","author":"Han","year":"2020","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.ajpath.2024.02.006_bib9","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1002\/hep.29533","article-title":"MicroRNA-506 promotes primary biliary cholangitis-like features in cholangiocytes and immune activation","volume":"67","author":"Erice","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2024.02.006_bib10","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/hep.29838","article-title":"Cholangiocyte-derived exosomal long noncoding RNA H19 promotes cholestatic liver injury in mouse and humans","volume":"68","author":"Li","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2024.02.006_bib11","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1056\/NEJMct074694","article-title":"Ursodeoxycholic acid for the treatment of primary biliary cirrhosis","volume":"357","author":"Lindor","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajpath.2024.02.006_bib12","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1016\/S0140-6736(10)61965-4","article-title":"Primary biliary cirrhosis","volume":"377","author":"Selmi","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.ajpath.2024.02.006_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0139305","article-title":"MicroRNAs in serum and bile of patients with primary sclerosing cholangitis and\/or cholangiocarcinoma","volume":"10","author":"Voigtlander","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ajpath.2024.02.006_bib14","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0140-6736(18)31877-4","article-title":"Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses","volume":"393","author":"Ovadia","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.ajpath.2024.02.006_bib15","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s12884-023-05456-1","article-title":"Unique microRNA expression profiles in plasmic exosomes from intrahepatic cholestasis of pregnancy","volume":"23","author":"Kong","year":"2023","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.ajpath.2024.02.006_bib16","doi-asserted-by":"crossref","first-page":"423","DOI":"10.4254\/wjh.v12.i8.423","article-title":"Review: pathogenesis of cholestatic liver diseases","volume":"12","author":"Yokoda","year":"2020","journal-title":"World J Hepatol"},{"key":"10.1016\/j.ajpath.2024.02.006_bib17","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1074\/jbc.M114.587030","article-title":"Post-translational regulation of the type III inositol 1,4,5-trisphosphate receptor by miRNA-506","volume":"290","author":"Ananthanarayanan","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ajpath.2024.02.006_bib18","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/hep.25691","article-title":"Up-regulation of microRNA 506 leads to decreased Cl-\/HCO3- anion exchanger 2 expression in biliary epithelium of patients with primary biliary cirrhosis","volume":"56","author":"Banales","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2024.02.006_bib19","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1002\/hep.30966","article-title":"MicroRNA-210 promotes bile acid-induced cholestatic liver injury by targeting mixed-lineage leukemia-4 methyltransferase in mice","volume":"71","author":"Kim","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2024.02.006_bib20","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1002\/hep.27578","article-title":"Crucial roles of mixed-lineage leukemia 3 and 4 as epigenetic switches of the hepatic circadian clock controlling bile acid homeostasis in mice","volume":"61","author":"Kim","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2024.02.006_bib21","doi-asserted-by":"crossref","first-page":"19233","DOI":"10.18632\/aging.103748","article-title":"CircRNA CDR1as promotes hepatoblastoma proliferation and stemness by acting as a miR-7-5p sponge to upregulate KLF4 expression","volume":"12","author":"Chen","year":"2020","journal-title":"Aging"},{"key":"10.1016\/j.ajpath.2024.02.006_bib22","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.3892\/etm.2014.1986","article-title":"Human leukocyte antigen G and miR-148a are associated with the pathogenesis of intrahepatic cholestasis of pregnancy","volume":"8","author":"Zhang","year":"2014","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.ajpath.2024.02.006_bib23","first-page":"607","article-title":"[MicroRNA-221\/222 participates in the pathogenesis of intrahepatic cholestasis of pregnancy via promoting the apoptosis of human placental trophoblast HTR-8 cells]","volume":"26","author":"Ji","year":"2018","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"10.1016\/j.ajpath.2024.02.006_bib24","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.reprotox.2017.08.002","article-title":"Cholestatic pregnancy is associated with reduced VCAM1 expression in vascular endothelial cell of placenta","volume":"74","author":"Qin","year":"2017","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.ajpath.2024.02.006_bib25","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/gut.49.1.131","article-title":"Tumour necrosis factor alpha impairs function of liver derived T lymphocytes and natural killer cells in patients with primary sclerosing cholangitis","volume":"49","author":"Bo","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.ajpath.2024.02.006_bib26","first-page":"50","article-title":"Serum IL-6 and IL-8 in infants with biliary atresia in comparison to intrahepatic cholestasis","volume":"32","author":"El-Faramawy","year":"2011","journal-title":"Trop Gastroenterol"},{"key":"10.1016\/j.ajpath.2024.02.006_bib27","doi-asserted-by":"crossref","first-page":"9784","DOI":"10.3390\/ijms23179784","article-title":"An update on the effects of vitamin D on the immune system and autoimmune diseases","volume":"23","author":"Sirbe","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajpath.2024.02.006_bib28","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/cei.12103","article-title":"Interleukin-32 production associated with biliary innate immunity and proinflammatory cytokines contributes to the pathogenesis of cholangitis in biliary atresia","volume":"173","author":"Okamura","year":"2013","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.ajpath.2024.02.006_bib29","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.3390\/jcm12041594","article-title":"Biliary atresia in adolescence and adult life: medical, surgical and psychological aspects","volume":"12","author":"Kelly","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.ajpath.2024.02.006_bib30","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3727\/105221620X15889714507961","article-title":"Downregulation of p16 decreases biliary damage and liver fibrosis in the Mdr2(\/) mouse model of primary sclerosing cholangitis","volume":"20","author":"Kyritsi","year":"2020","journal-title":"Gene Expr"},{"key":"10.1016\/j.ajpath.2024.02.006_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2020.165895","article-title":"S-adenosyl-L-methionine (SAMe) halts the autoimmune response in patients with primary biliary cholangitis (PBC) via antioxidant and S-glutathionylation processes in cholangiocytes","volume":"1866","author":"Kilanczyk","year":"2020","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.ajpath.2024.02.006_bib32","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/s41418-017-0019-x","article-title":"miRNA-21 ablation protects against liver injury and necroptosis in cholestasis","volume":"25","author":"Afonso","year":"2018","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.ajpath.2024.02.006_bib33","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1038\/labinvest.2016.112","article-title":"Knockout of microRNA-21 reduces biliary hyperplasia and liver fibrosis in cholestatic bile duct ligated mice","volume":"96","author":"Kennedy","year":"2016","journal-title":"Lab Invest"},{"key":"10.1016\/j.ajpath.2024.02.006_bib34","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3390\/jcm5030028","article-title":"Circulating miR-21 and miR-29a as markers of disease severity and etiology in cholestatic pediatric liver disease","volume":"5","author":"Goldschmidt","year":"2016","journal-title":"J Clin Med"},{"key":"10.1016\/j.ajpath.2024.02.006_bib35","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s10020-019-0130-1","article-title":"Enhanced expression of miR-21 and miR-150 is a feature of anti-mitochondrial antibody-negative primary biliary cholangitis","volume":"26","author":"Wasik","year":"2020","journal-title":"Mol Med"},{"key":"10.1016\/j.ajpath.2024.02.006_bib36","doi-asserted-by":"crossref","first-page":"E189","DOI":"10.1111\/hepr.12198","article-title":"Expression of micro-RNAs in peripheral blood mononuclear cells from primary biliary cirrhosis patients","volume":"44","author":"Katsushima","year":"2014","journal-title":"Hepatol Res"},{"key":"10.1016\/j.ajpath.2024.02.006_bib37","doi-asserted-by":"crossref","first-page":"12481","DOI":"10.1073\/pnas.0605298103","article-title":"NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses","volume":"103","author":"Taganov","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ajpath.2024.02.006_bib38","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3390\/ijms18020289","article-title":"Decreased expression of vitamin D receptor affects an immune response in primary biliary cholangitis via the VDR-miRNA155-SOCS1 pathway","volume":"18","author":"Kempinska-Podhorodecka","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajpath.2024.02.006_bib39","doi-asserted-by":"crossref","first-page":"315","DOI":"10.4077\/CJP.2016.BAE419","article-title":"Effect of microRNA-155 on the interferon-gamma signaling pathway in biliary atresia","volume":"59","author":"Hsu","year":"2016","journal-title":"Chin J Physiol"},{"key":"10.1016\/j.ajpath.2024.02.006_bib40","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/pr.2017.87","article-title":"MicroRNA-155 modulates bile duct inflammation by targeting the suppressor of cytokine signaling 1 in biliary atresia","volume":"82","author":"Zhao","year":"2017","journal-title":"Pediatr Res"},{"key":"10.1016\/j.ajpath.2024.02.006_bib41","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1038\/labinvest.2016.95","article-title":"MiR-139-5p is associated with inflammatory regulation through c-FOS suppression, and contributes to the progression of primary biliary cholangitis","volume":"96","author":"Katsumi","year":"2016","journal-title":"Lab Invest"},{"key":"10.1016\/j.ajpath.2024.02.006_bib42","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.4049\/jimmunol.1202534","article-title":"Human neonatal naive CD4+ T cells have enhanced activation-dependent signaling regulated by the microRNA miR-181a","volume":"190","author":"Palin","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.ajpath.2024.02.006_bib43","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.intimp.2018.09.027","article-title":"miR-181a regulates Th17 cells distribution via up-regulated BCL-2 in primary biliary cholangitis","volume":"64","author":"Song","year":"2018","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.ajpath.2024.02.006_bib44","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3892\/ijmm.2016.2610","article-title":"Altered expression of miR-92a correlates with Th17 cell frequency in patients with primary biliary cirrhosis","volume":"38","author":"Liang","year":"2016","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.ajpath.2024.02.006_bib45","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.jhep.2017.02.002","article-title":"miR-425 regulates inflammatory cytokine production in CD4(+) T cells via N-Ras upregulation in primary biliary cholangitis","volume":"66","author":"Nakagawa","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajpath.2024.02.006_bib46","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.jhep.2014.10.033","article-title":"Dysregulated miR-124 and miR-200 expression contribute to cholangiocyte proliferation in the cholestatic liver by targeting IL-6\/STAT3 signalling","volume":"62","author":"Xiao","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajpath.2024.02.006_bib47","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.molcel.2007.05.017","article-title":"Transcriptional activation of miR-34a contributes to p53-mediated apoptosis","volume":"26","author":"Raver-Shapira","year":"2007","journal-title":"Mol Cell"},{"key":"10.1016\/j.ajpath.2024.02.006_bib48","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/6890423","article-title":"MicroRNA-34a promotes EMT and liver fibrosis in primary biliary cholangitis by regulating TGF-beta1\/smad pathway","volume":"2021","author":"Pan","year":"2021","journal-title":"J Immunol Res"},{"key":"10.1016\/j.ajpath.2024.02.006_bib49","doi-asserted-by":"crossref","first-page":"9667","DOI":"10.3390\/ijms21249667","article-title":"Melatonin protects cholangiocytes from oxidative stress-induced proapoptotic and proinflammatory stimuli via miR-132 and miR-34","volume":"21","author":"Ostrycharz","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajpath.2024.02.006_bib50","doi-asserted-by":"crossref","DOI":"10.1038\/srep44769","article-title":"Protection against oxidative stress mediated by the Nrf2\/Keap1 axis is impaired in primary biliary cholangitis","volume":"7","author":"Wasik","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajpath.2024.02.006_bib51","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1038\/s41598-022-06809-0","article-title":"Protein and miRNA profile of circulating extracellular vesicles in patients with primary sclerosing cholangitis","volume":"12","author":"Povero","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajpath.2024.02.006_bib52","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1620\/tjem.240.269","article-title":"Interleukin-17A-induced epithelial-mesenchymal transition of human intrahepatic biliary epithelial cells: implications for primary biliary cirrhosis","volume":"240","author":"Huang","year":"2016","journal-title":"Tohoku J Exp Med"},{"key":"10.1016\/j.ajpath.2024.02.006_bib53","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s10620-016-4411-z","article-title":"MicroRNA-19b expression in human biliary atresia specimens and its role in BA-related fibrosis","volume":"62","author":"Zhao","year":"2017","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.ajpath.2024.02.006_bib54","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/571353","article-title":"Liver expression of sulphotransferase 2A1 enzyme is impaired in patients with primary sclerosing cholangitis: lack of the response to enhanced expression of PXR","volume":"2015","author":"Wunsch","year":"2015","journal-title":"J Immunol Res"},{"key":"10.1016\/j.ajpath.2024.02.006_bib55","doi-asserted-by":"crossref","first-page":"145","DOI":"10.15403\/jgld.2014.1121.272.cho","article-title":"Serum miRNA-122 is an independent biomarker of survival in patients with primary sclerosing cholangitis","volume":"27","author":"Friedrich","year":"2018","journal-title":"J Gastrointestin Liver Dis"},{"key":"10.1016\/j.ajpath.2024.02.006_bib56","article-title":"Evaluation of plasma microRNA-122, high-mobility group box 1 and keratin-18 concentrations to stratify acute gallstone disease: a pilot observational cohort study in an emergency general surgery unit","volume":"8","author":"Th'ng","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.ajpath.2024.02.006_bib57","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/MPG.0b013e318264e648","article-title":"Circulating microRNA is a biomarker of biliary atresia","volume":"55","author":"Zahm","year":"2012","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.ajpath.2024.02.006_bib58","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1097\/MPG.0000000000001194","article-title":"Identification of circulating microRNAs in biliary atresia by next-generation sequencing","volume":"63","author":"Peng","year":"2016","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.ajpath.2024.02.006_bib59","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.832577","article-title":"Serum exosomes microRNAs are novel non-invasive biomarkers of intrahepatic cholestasis of pregnancy","volume":"13","author":"Dong","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.ajpath.2024.02.006_bib60","first-page":"229","article-title":"A novel microRNA signature for cholestatic drugs in human hepatocytes and its translation into novel circulating biomarkers for drug-induced liver injury patients","volume":"173","author":"Lopez-Riera","year":"2020","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.ajpath.2024.02.006_bib61","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3390\/pathogens9060514","article-title":"Changes in miR-122 and cholesterol expression in chronic hepatitis C patients after PegIFN-alpha\/ribavirin treatment","volume":"9","author":"Sidorkiewicz","year":"2020","journal-title":"Pathogens"},{"key":"10.1016\/j.ajpath.2024.02.006_bib62","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1136\/gutjnl-2020-322526","article-title":"MicroRNAs as regulators, biomarkers and therapeutic targets in liver diseases","volume":"70","author":"Wang","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.ajpath.2024.02.006_bib63","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0073133","article-title":"Circulating liver-specific miR-122 as a novel potential biomarker for diagnosis of cholestatic liver injury","volume":"8","author":"Shifeng","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ajpath.2024.02.006_bib64","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.taap.2013.09.023","article-title":"Plasma biomarkers of liver injury and inflammation demonstrate a lack of apoptosis during obstructive cholestasis in mice","volume":"273","author":"Woolbright","year":"2013","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.ajpath.2024.02.006_bib65","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00210-018-1560-y","article-title":"Targeting HMGB1\/TLR4 axis and miR-21 by rosuvastatin: role in alleviating cholestatic liver injury in a rat model of bile duct ligation","volume":"392","author":"Nabih","year":"2019","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.ajpath.2024.02.006_bib66","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1089\/ars.2014.6027","article-title":"Activation of a novel c-Myc-miR27-prohibitin 1 circuitry in cholestatic liver injury inhibits glutathione synthesis in mice","volume":"22","author":"Yang","year":"2015","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.ajpath.2024.02.006_bib67","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.737313","article-title":"Effect of miR-183-5p on cholestatic liver fibrosis by regulating fork head box protein O1 expression","volume":"12","author":"Wang","year":"2021","journal-title":"Front Physiol"},{"key":"10.1016\/j.ajpath.2024.02.006_bib68","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1089\/ars.2021.0023","article-title":"Circulating extracellular vesicles contain liver-derived RNA species as indicators of severe cholestasis-induced early liver fibrosis in mice","volume":"36","author":"Fagoonee","year":"2022","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.ajpath.2024.02.006_bib69","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3390\/ijms17030324","article-title":"Microarray study of pathway analysis expression profile associated with microRNA-29a with regard to murine cholestatic liver injuries","volume":"17","author":"Li","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajpath.2024.02.006_bib70","doi-asserted-by":"crossref","first-page":"212","DOI":"10.7150\/ijms.29930","article-title":"MicroRNA-29a is a key regulon that regulates BRD4 and mitigates liver fibrosis in mice by inhibiting hepatic stellate cell activation","volume":"16","author":"Huang","year":"2019","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.ajpath.2024.02.006_bib71","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.3390\/ijms21103636","article-title":"Exogenous therapeutics of microrna-29a attenuates development of hepatic fibrosis in cholestatic animal model through regulation of phosphoinositide 3-kinase p85 alpha","volume":"21","author":"Yang","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajpath.2024.02.006_bib72","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/5180579","article-title":"Human chorionic plate-derived mesenchymal stem cells restore hepatic lipid metabolism in a rat model of bile duct ligation","volume":"2017","author":"Lee","year":"2017","journal-title":"Stem Cells Int"},{"key":"10.1016\/j.ajpath.2024.02.006_bib73","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.ajpath.2013.11.008","article-title":"Regulation of the histamine\/VEGF axis by miR-125b during cholestatic liver injury in mice","volume":"184","author":"Meng","year":"2014","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ajpath.2024.02.006_bib74","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/s41374-021-00710-6","article-title":"MiR-200c-3p targets SESN1 and represses the IL-6\/AKT loop to prevent cholangiocyte activation and cholestatic liver fibrosis","volume":"102","author":"Song","year":"2022","journal-title":"Lab Invest"},{"key":"10.1016\/j.ajpath.2024.02.006_bib75","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/MPG.0b013e318244148b","article-title":"MicroRNA profiling identifies miR-29 as a regulator of disease-associated pathways in experimental biliary atresia","volume":"54","author":"Hand","year":"2012","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.ajpath.2024.02.006_bib76","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1002\/jat.4144","article-title":"Plasma miR-218a-5p as a biomarker for acute cholestatic liver injury in rats and investigation of its pathophysiological roles","volume":"41","author":"Oda","year":"2021","journal-title":"J Appl Toxicol"},{"key":"10.1016\/j.ajpath.2024.02.006_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2021.114709","article-title":"miRNA and miRNA target genes in intervention effect of Zhuyu pill on cholestatic rat model","volume":"283","author":"Yu","year":"2022","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.ajpath.2024.02.006_bib78","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1038\/s41374-018-0093-9","article-title":"Knockout of secretin receptor reduces biliary damage and liver fibrosis in Mdr2(-\/-) mice by diminishing senescence of cholangiocytes","volume":"98","author":"Zhou","year":"2018","journal-title":"Lab Invest"},{"key":"10.1016\/j.ajpath.2024.02.006_bib79","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jhep.2021.02.035","article-title":"Limb expression 1-like (LIX1L) protein promotes cholestatic liver injury by regulating bile acid metabolism","volume":"75","author":"Li","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.ajpath.2024.02.006_bib80","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12870-018-1238-0","article-title":"Identification of gossypium hirsutum long non-coding RNAs (lncRNAs) under salt stress","volume":"18","author":"Deng","year":"2018","journal-title":"BMC Plant Biol"},{"key":"10.1016\/j.ajpath.2024.02.006_bib81","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.trsl.2020.11.010","article-title":"Long noncoding RNA H19 - a new player in the pathogenesis of liver diseases","volume":"230","author":"Yang","year":"2021","journal-title":"Transl Res"},{"key":"10.1016\/j.ajpath.2024.02.006_bib82","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1002\/hep.30698","article-title":"Long noncoding RNA H19 contributes to cholangiocyte proliferation and cholestatic liver fibrosis in biliary atresia","volume":"70","author":"Xiao","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2024.02.006_bib83","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.30662","article-title":"Cholangiocyte-derived exosomal long noncoding RNA H19 promotes hepatic stellate cell activation and cholestatic liver fibrosis","volume":"70","author":"Liu","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2024.02.006_bib84","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1002\/hep.29209","article-title":"H19 promotes cholestatic liver fibrosis by preventing ZEB1-mediated inhibition of epithelial cell adhesion molecule","volume":"66","author":"Song","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2024.02.006_bib85","article-title":"Bcl2 is a critical regulator of bile acid homeostasis by dictating Shp and lncRNA H19 function","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.ajpath.2024.02.006_bib86","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/s41419-021-03931-1","article-title":"Conditional depletion of macrophages ameliorates cholestatic liver injury and fibrosis via lncRNA-H19","volume":"12","author":"Tian","year":"2021","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.ajpath.2024.02.006_bib87","doi-asserted-by":"crossref","first-page":"9698","DOI":"10.1002\/jcp.27656","article-title":"H19\/miR-148a\/USP4 axis facilitates liver fibrosis by enhancing TGF-beta signaling in both hepatic stellate cells and hepatocytes","volume":"234","author":"Zhu","year":"2019","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.ajpath.2024.02.006_bib88","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3390\/cells9010190","article-title":"Cholangiocyte-derived exosomal lncRNA H19 promotes macrophage activation and hepatic inflammation under cholestatic conditions","volume":"9","author":"Li","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.ajpath.2024.02.006_bib89","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1046\/j.1365-2443.2000.00320.x","article-title":"Identification of an imprinted gene, Meg3\/Gtl2 and its human homologue MEG3, first mapped on mouse distal chromosome 12 and human chromosome 14q","volume":"5","author":"Miyoshi","year":"2000","journal-title":"Genes Cell"},{"key":"10.1016\/j.ajpath.2024.02.006_bib90","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1210\/en.2009-0657","article-title":"Maternally expressed gene 3 (MEG3) noncoding ribonucleic acid: isoform structure, expression, and functions","volume":"151","author":"Zhang","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/j.ajpath.2024.02.006_bib91","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.bbrc.2015.11.048","article-title":"Upregulation of lncRNA MEG3 promotes hepatic insulin resistance via increasing FoxO1 expression","volume":"469","author":"Zhu","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ajpath.2024.02.006_bib92","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1016\/j.bbadis.2014.08.015","article-title":"Inhibitory effects of long noncoding RNA MEG3 on hepatic stellate cells activation and liver fibrogenesis","volume":"1842","author":"He","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ajpath.2024.02.006_bib93","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/hep.28882","article-title":"Long noncoding RNA MEG3 induces cholestatic liver injury by interaction with PTBP1 to facilitate shp mRNA decay","volume":"65","author":"Zhang","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.ajpath.2024.02.006_bib94","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3390\/cells12020215","article-title":"The fibrotic effects of LINC00663 in human hepatic stellate LX-2 cells and in bile duct-ligated cholestasis mice are mediated through the splicing factor 2-fibronectin","volume":"12","author":"Chu","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.ajpath.2024.02.006_bib95","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.209619","article-title":"TGF-beta induces oncofetal fibronectin that, in turn, modulates TGF-beta superfamily signaling in endothelial cells","volume":"131","author":"Ventura","year":"2018","journal-title":"J Cell Sci"},{"key":"10.1016\/j.ajpath.2024.02.006_bib96","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1111\/liv.14476","article-title":"Integration of miRNA-regulatory networks in hepatic stellate cells identifies TIMP3 as a key factor in chronic liver disease","volume":"40","author":"Azar","year":"2020","journal-title":"Liver Int"}],"container-title":["The American Journal of Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944024000750?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002944024000750?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T03:29:43Z","timestamp":1731468583000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002944024000750"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":96,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S0002944024000750"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpath.2024.02.006","relation":{},"ISSN":["0002-9440"],"issn-type":[{"value":"0002-9440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Role of miRNA and Long Noncoding RNA in Cholestatic Liver Diseases","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpath.2024.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Society for Investigative Pathology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}